![](/img/cover-not-exists.png)
ANTITHROMBOTIC THERAPY AND CARDIOVASCULAR RISK IN PATIENTS WITH ATRIAL FIBRILLATION AT HIGH RISK FOR THROMBOEMBOLIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL
Kosmidou, Ioanna, Madhavan, Mahesh, Liu, Yangbo, Alu, Maria, Biviano, Angelo, Chakravarty, Tarun, Makkar, Raj, Thourani, Vinod, Kodali, Susheel, Leon, MartinVolume:
73
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(19)31643-2
Date:
March, 2019
File:
PDF, 182 KB
2019